<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinform Biol Insights</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinform Biol Insights</journal-id>
    <journal-id journal-id-type="publisher-id">BBI</journal-id>
    <journal-id journal-id-type="hwp">spbbi</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics and Biology Insights</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1177-9322</issn>
    <publisher>
      <publisher-name>SAGE Publications</publisher-name>
      <publisher-loc>Sage UK: London, England</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6698994</article-id>
    <article-id pub-id-type="doi">10.1177/1177932219868223</article-id>
    <article-id pub-id-type="publisher-id">10.1177_1177932219868223</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Commentary</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Top-Down and Intact Protein Mass Spectrometry Data Visualization for
Proteoform Analysis Using VisioProt-MS</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Lesne</surname>
          <given-names>Jean</given-names>
        </name>
        <xref ref-type="aff" rid="aff1-1177932219868223">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bousquet</surname>
          <given-names>Marie-Pierre</given-names>
        </name>
        <xref ref-type="aff" rid="aff1-1177932219868223">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7321-7436</contrib-id>
        <name>
          <surname>Marcoux</surname>
          <given-names>Julien</given-names>
        </name>
        <xref ref-type="aff" rid="aff1-1177932219868223">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2879-9224</contrib-id>
        <name>
          <surname>Locard-Paulet</surname>
          <given-names>Marie</given-names>
        </name>
        <xref ref-type="aff" rid="aff2-1177932219868223">2</xref>
        <xref ref-type="corresp" rid="corresp2-1177932219868223"/>
      </contrib>
    </contrib-group>
    <aff id="aff1-1177932219868223"><label>1</label>Institut de Pharmacologie et de Biologie
Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France</aff>
    <aff id="aff2-1177932219868223"><label>2</label>Disease Systems Biology Program, Novo
Nordisk Foundation Center for Protein Research, University of Copenhagen,
Copenhagen, Denmark</aff>
    <author-notes>
      <corresp id="corresp1-1177932219868223">Julien Marcoux, Institut de Pharmacologie et
de Biologie Structurale, Université de Toulouse, CNRS, UPS, 205 route de
Narbonne 31077, Toulouse, France. Email:
<email>julien.marcoux@ipbs.fr</email></corresp>
      <corresp id="corresp2-1177932219868223">Marie Locard-Paulet, Disease Systems Biology
Program, Novo Nordisk Foundation Center for Protein Research, University of
Copenhagen, DK-2200 Copenhagen N, Denmark. Email:
<email>marie.locard-paulet@cpr.ku.dk</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>16</day>
      <month>8</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2019</year>
    </pub-date>
    <volume>13</volume>
    <elocation-id>1177932219868223</elocation-id>
    <history>
      <date date-type="received">
        <day>11</day>
        <month>7</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>17</day>
        <month>7</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2019</copyright-statement>
      <copyright-year>2019</copyright-year>
      <copyright-holder content-type="sage">SAGE Publications Ltd unless otherwise noted.
Manuscript content on this site is licensed under Creative Commons
Licenses</copyright-holder>
      <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This article is distributed under the terms of the Creative Commons
Attribution 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by/4.0/">http://www.creativecommons.org/licenses/by/4.0/</ext-link>) which
permits any use, reproduction and distribution of the work without further
permission provided the original work is attributed as specified on the SAGE
and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
      </license>
    </permissions>
    <related-article related-article-type="commentary-article" id="d35e131" ext-link-type="doi" xlink:href="10.1093/bioinformatics/bty680" issue="4" page="679" vol="35"/>
    <abstract>
      <p>The rise of intact protein analysis by mass spectrometry (MS) was accompanied by
an increasing need for flexible tools allowing data visualization and analysis.
These include inspection of the deconvoluted molecular weights of the
proteoforms eluted alongside liquid chromatography (LC) through their
representation in three-dimensional (3D) liquid chromatography coupled to mass
spectrometry (LC-MS) maps (plots of deconvoluted molecular weights, retention
times, and intensity of the MS signal). With this aim, we developed a free and
open-source web application named VisioProt-MS (<ext-link ext-link-type="uri" xlink:href="https://masstools.ipbs.fr/mstools/visioprot-ms/">https://masstools.ipbs.fr/mstools/visioprot-ms/</ext-link>). VisioProt-MS
is highly compatible with many algorithms and software developed by the
community to integrate and deconvolute top-down and intact protein MS data. Its
dynamic and user-friendly features greatly facilitate analysis through several
graphical representations dedicated to MS and tandem mass spectrometry (MS/MS)
analysis of proteoforms in complex samples. Here, we will illustrate the
importance of LC-MS map visualization to optimize top-down acquisition/search
parameters and analyze intact protein MS data. We will go through the main
features of VisioProt-MS using the human proteasomal 20S core particle as a
user-case.</p>
    </abstract>
    <kwd-group>
      <kwd>Mass spectrometry</kwd>
      <kwd>proteasome</kwd>
      <kwd>top-down</kwd>
      <kwd>LC-MS</kwd>
      <kwd>intact protein MS</kwd>
    </kwd-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>cover-date</meta-name>
        <meta-value>January-December 2019</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <p><bold>Comment on:</bold> Locard-Paulet M, Parra J, Albigot R, et al. VisioProt-MS:
interactive 2D maps from intact protein mass spectrometry.
<italic>Bioinformatics</italic>. 2019;35(4):679-681. doi:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/bty680">10.1093/bioinformatics/bty680</ext-link>. PubMed PMID:30084957. PubMed Central
PMCID:PMC6378940. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378940/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378940/</ext-link>.</p>
  <sec sec-type="intro" id="section1-1177932219868223">
    <title>Introduction</title>
    <p>Top-down proteomics consists in the analysis of intact proteins using liquid
chromatography coupled to mass spectrometry (LC-MS), followed by their
identification by tandem mass spectrometry (MS/MS). This informs on the protein
composition of the analyzed sample, and their potential combinations of
post-translational modifications, splicing events, and/or mutations. Intact protein
mass spectrometry (MS) recently increased in throughput<sup><xref rid="bibr1-1177932219868223" ref-type="bibr">1</xref></sup> and became quantitative,<sup><xref rid="bibr2-1177932219868223" ref-type="bibr">2</xref>,<xref rid="bibr3-1177932219868223" ref-type="bibr">3</xref></sup> thereby allowing the in-depth
characterization of proteoforms<sup><xref rid="bibr4-1177932219868223" ref-type="bibr">4</xref></sup> in complex samples.<sup><xref rid="bibr5-1177932219868223" ref-type="bibr">5</xref></sup> Such development was associated with the establishment of a specific
lexicon,<sup><xref rid="bibr6-1177932219868223" ref-type="bibr">6</xref>,<xref rid="bibr7-1177932219868223" ref-type="bibr">7</xref></sup>
dedicated databases (<ext-link ext-link-type="uri" xlink:href="http://repository.topdownproteomics.org">repository.topdownproteomics.org</ext-link>), and, needless to say, a panel of
bioinformatics tools.<sup><xref rid="bibr8-1177932219868223" ref-type="bibr">8</xref><xref rid="bibr9-1177932219868223" ref-type="bibr"/><xref rid="bibr10-1177932219868223" ref-type="bibr"/>-<xref rid="bibr11-1177932219868223" ref-type="bibr">11</xref></sup></p>
    <p>Typically, top-down and intact protein MS analysis relies on the measurement of the
deconvoluted molecular weights (MWs) of proteoforms after separation by liquid
chromatography (LC). This can be facilitated by the graphical representation of
LC-MS three-dimensional (3D) maps, where the <italic>x</italic>-axis represents
retention time (RT), the <italic>y</italic>-axis represents deconvoluted MW, and the
color represents the intensity of the MS signal. In addition, directly comparing
these maps reveals differences in proteoform footprints between samples and/or
experimental conditions.<sup><xref rid="bibr1-1177932219868223" ref-type="bibr">1</xref>,<xref rid="bibr8-1177932219868223" ref-type="bibr">8</xref>,<xref rid="bibr12-1177932219868223" ref-type="bibr">12</xref><xref rid="bibr13-1177932219868223" ref-type="bibr"/><xref rid="bibr14-1177932219868223" ref-type="bibr"/><xref rid="bibr15-1177932219868223" ref-type="bibr"/>–<xref rid="bibr16-1177932219868223" ref-type="bibr">16</xref></sup> Recently, we developed a free
standalone tool to facilitate this analytical step: VisioProt-MS.<sup><xref rid="bibr17-1177932219868223" ref-type="bibr">17</xref></sup> Here, we will illustrate its use through the analysis of the 20S core
particle of the human proteasome.</p>
    <p>The proteasome is a ubiquitous macromolecular barrel-shaped complex of around 700 kDa
that is responsible for protein degradation in eukaryotic cells.<sup><xref rid="bibr18-1177932219868223" ref-type="bibr">18</xref></sup> It is vital to maintain protein homeostasis and the pool of free amino acids
available for protein synthesis. It also contributes to the immune response through
production of antigenic peptides. Its catalytic activity resides in the 20S core
particle that is composed of 4 rings of 7 subunits each: two β-rings (β1-7)
surrounded by two α-rings (α1-7). The names and theoretical MWs of these subunits
are presented in <xref rid="table1-1177932219868223" ref-type="table">Table
1</xref>. β1, β2, and β5 are the only subunits that are catalytically active in the
standard 20S (std20S), and they can be replaced by β1i, β2i, and β5i to form the
immunoproteasome (i20S) in the context of immune response. This leads to 2 different
functional complexes that have distinct catalytic activities.<sup><xref rid="bibr19-1177932219868223" ref-type="bibr">19</xref></sup> The proteasome is highly studied in academia and industry in the context of
drug development. The 20S core particle can be immunopurified using the anti-α2
antibody MCP21,<sup><xref rid="bibr20-1177932219868223" ref-type="bibr">20</xref>,<xref rid="bibr21-1177932219868223" ref-type="bibr">21</xref></sup> and as it is constituted of subunits of ~20 to ~30 kDa, it is
specifically suited for top-down and intact protein MS analysis.<sup><xref rid="bibr8-1177932219868223" ref-type="bibr">8</xref></sup> We present here the comparative top-down analysis of in-house-produced std20S
and commercial samples of purified std20S and i20S using VisioProt-MS.</p>
    <table-wrap id="table1-1177932219868223" orientation="portrait" position="float">
      <label>Table 1.</label>
      <caption>
        <p>Theoretical molecular weights of the subunits composing the 20S core particle
of the proteasome.</p>
      </caption>
      <alternatives>
        <graphic xlink:href="10.1177_1177932219868223-table1"/>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="char" char="." span="1"/>
            <col align="char" char="." span="1"/>
            <col align="char" char="." span="1"/>
            <col align="char" char="." span="1"/>
            <col align="char" char="." span="1"/>
            <col align="char" char="." span="1"/>
            <col align="char" char="." span="1"/>
            <col align="char" char="." span="1"/>
            <col align="char" char="." span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Subunit name</th>
              <th align="left" rowspan="1" colspan="1">Gene name</th>
              <th align="left" rowspan="1" colspan="1">UniProt accession</th>
              <th align="left" rowspan="1" colspan="1">Sequence</th>
              <th align="left" rowspan="1" colspan="1">Theoretical MW (Da)</th>
              <th align="left" rowspan="1" colspan="1">-Met</th>
              <th align="left" rowspan="1" colspan="1">Mature protein</th>
              <th align="left" rowspan="1" colspan="1">-Met + 1ac</th>
              <th align="left" rowspan="1" colspan="1">+1ac</th>
              <th align="left" rowspan="1" colspan="1">-Met + 1ac + 1phos</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">α1</td>
              <td rowspan="1" colspan="1">
                <italic>PSMA6</italic>
              </td>
              <td rowspan="1" colspan="1">P60900</td>
              <td rowspan="1" colspan="1">2-246</td>
              <td rowspan="1" colspan="1">27 399.45</td>
              <td rowspan="1" colspan="1">27 268.26</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>27 310.27</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1">27 441.46</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">α2</td>
              <td rowspan="1" colspan="1">
                <italic>PSMA2</italic>
              </td>
              <td rowspan="1" colspan="1">P25787</td>
              <td rowspan="1" colspan="1">2-234</td>
              <td rowspan="1" colspan="1">25 898.59</td>
              <td rowspan="1" colspan="1">25 767.40</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>25 809.41</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1">25 940.60</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">α3</td>
              <td rowspan="1" colspan="1">
                <italic>PSMA4</italic>
              </td>
              <td rowspan="1" colspan="1">P25789</td>
              <td rowspan="1" colspan="1">2-261</td>
              <td rowspan="1" colspan="1">29 483.81</td>
              <td rowspan="1" colspan="1">29 352.62</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>29 394.63</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1">29 525.82</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">α4</td>
              <td rowspan="1" colspan="1">
                <italic>PSMA7</italic>
              </td>
              <td rowspan="1" colspan="1">O14818</td>
              <td rowspan="1" colspan="1">2-248</td>
              <td rowspan="1" colspan="1">27 886.85</td>
              <td rowspan="1" colspan="1">27 755.66</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>27 797.67</bold>
                <sup>
                  <xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>
                </sup>
              </td>
              <td rowspan="1" colspan="1">27 928.86</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">α5</td>
              <td rowspan="1" colspan="1">
                <italic>PSMA5</italic>
              </td>
              <td rowspan="1" colspan="1">P28066</td>
              <td rowspan="1" colspan="1">1-241</td>
              <td rowspan="1" colspan="1">26 411.03</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>26 453.04</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">α6</td>
              <td rowspan="1" colspan="1">
                <italic>PSMA1</italic>
              </td>
              <td rowspan="1" colspan="1">P25786</td>
              <td rowspan="1" colspan="1">1-263</td>
              <td rowspan="1" colspan="1">29 555.59</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>29 597.60</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">α7</td>
              <td rowspan="1" colspan="1">
                <italic>PSMA3</italic>
              </td>
              <td rowspan="1" colspan="1">P25788</td>
              <td rowspan="1" colspan="1">2-255</td>
              <td rowspan="1" colspan="1">28 433.23</td>
              <td rowspan="1" colspan="1">28 302.04</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>28 344.05</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1">28 475.24</td>
              <td rowspan="1" colspan="1">
                <bold>28 424.02</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>β1</bold>
              </td>
              <td rowspan="1" colspan="1">
                <italic>PSMB6</italic>
              </td>
              <td rowspan="1" colspan="1">P28072</td>
              <td rowspan="1" colspan="1">35-239</td>
              <td rowspan="1" colspan="1">25 357.72</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>21 903.89</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref></sup>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">21 945.90</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>β1i</bold>
              </td>
              <td rowspan="1" colspan="1">
                <italic>PSMB9</italic>
              </td>
              <td rowspan="1" colspan="1">P28065</td>
              <td rowspan="1" colspan="1">21-219</td>
              <td rowspan="1" colspan="1">23 264.30</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>21 276.05</bold>
                <sup>
                  <xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref>
                </sup>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">21 318.06</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>β2</bold>
              </td>
              <td rowspan="1" colspan="1">
                <italic>PSMB7</italic>
              </td>
              <td rowspan="1" colspan="1">Q99436</td>
              <td rowspan="1" colspan="1">44-277</td>
              <td rowspan="1" colspan="1">29 965.42</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>25 294.99</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">30 007.43</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>β2i</bold>
              </td>
              <td rowspan="1" colspan="1">
                <italic>PSMB10</italic>
              </td>
              <td rowspan="1" colspan="1">P40306</td>
              <td rowspan="1" colspan="1">40-273</td>
              <td rowspan="1" colspan="1">28 936.30</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>24 648.28</bold>
                <sup>
                  <xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref>
                </sup>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">28 978.31</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">β3</td>
              <td rowspan="1" colspan="1">
                <italic>PSMB3</italic>
              </td>
              <td rowspan="1" colspan="1">P49720</td>
              <td rowspan="1" colspan="1">2-205</td>
              <td rowspan="1" colspan="1">22 948.88</td>
              <td rowspan="1" colspan="1">22 817.69</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>22 859.70</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1">22 990.89</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">β4</td>
              <td rowspan="1" colspan="1">
                <italic>PSMB2</italic>
              </td>
              <td rowspan="1" colspan="1">P49721</td>
              <td rowspan="1" colspan="1">1-201</td>
              <td rowspan="1" colspan="1">22 836.28</td>
              <td rowspan="1" colspan="1">22 705.09</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">22 747.10</td>
              <td rowspan="1" colspan="1">
                <bold>22 878.29</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>β5</bold>
              </td>
              <td rowspan="1" colspan="1">
                <italic>PSMB5</italic>
              </td>
              <td rowspan="1" colspan="1">P28074</td>
              <td rowspan="1" colspan="1">60-263</td>
              <td rowspan="1" colspan="1">28 480.28</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>22 458.37</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">28 522.29</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>β5i</bold>
              </td>
              <td rowspan="1" colspan="1">
                <italic>PSMB8</italic>
              </td>
              <td rowspan="1" colspan="1">P28062</td>
              <td rowspan="1" colspan="1">73-276</td>
              <td rowspan="1" colspan="1">30 354.26</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>22 659.61</bold>
                <sup>
                  <xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref>
                </sup>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">30 396.27</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">β6</td>
              <td rowspan="1" colspan="1">
                <italic>PSMB1</italic>
              </td>
              <td rowspan="1" colspan="1">P20618</td>
              <td rowspan="1" colspan="1">29-241</td>
              <td rowspan="1" colspan="1">26 489.37</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>23 548.94</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">26 531.38</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">β7</td>
              <td rowspan="1" colspan="1">
                <italic>PSMB4</italic>
              </td>
              <td rowspan="1" colspan="1">P28070</td>
              <td rowspan="1" colspan="1">46-264</td>
              <td rowspan="1" colspan="1">29 204.24</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">
                <bold>24 391.78</bold>
                <sup><xref ref-type="table-fn" rid="table-fn3-1177932219868223">a</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">b</xref>,<xref ref-type="table-fn" rid="table-fn3-1177932219868223">c</xref></sup>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">29 246.25</td>
              <td rowspan="1" colspan="1"/>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn id="table-fn1-1177932219868223">
          <p>Abbreviation: MW, molecular weight.</p>
        </fn>
        <fn id="table-fn2-1177932219868223">
          <p>“-Met”: loss of <italic>N</italic>-terminal methionine; “Mature protein”:
loss of <italic>N</italic>-terminal propeptide; “ac”: acetylation;
“phos”: phosphorylation.</p>
        </fn>
        <fn id="table-fn3-1177932219868223">
          <p>β1/β2/β5 and β1i/β2i/β5i are specific subunits of the std20 and i20S,
respectively. The most abundant proteoforms identified in <xref ref-type="fig" rid="fig1-1177932219868223">Figures 1</xref> and
<xref ref-type="fig" rid="fig2-1177932219868223">2A</xref> and <xref ref-type="fig" rid="fig2-1177932219868223">B</xref> are indicated in
bold with the superscripts a, b, and c, respectively.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </sec>
  <sec sec-type="materials|methods" id="section2-1177932219868223">
    <title>Material and Methods</title>
    <sec id="section3-1177932219868223">
      <title>Reagents</title>
      <p>All reagents were provided by Sigma-Aldrich unless otherwise specified.
Commercial standard and immuno-20S were purchased from Enzo Life Science.</p>
    </sec>
    <sec id="section4-1177932219868223">
      <title>In-house purification of endogenous 20S</title>
      <p>Endogenous 20S was purified from Hek293-EBNA cells grown to 80% confluency in
Iscove’s Modified Dulbecco’s Medium (IMDM; Thermo Fisher) supplemented with 10%
fetal bovine serum (FBS), 116 mg/mL L-Arginine, and 36 mg/mL L-asparagine (Acros
Organics) at 37°C and 5% CO<sub>2</sub>. Cells were then washed twice with
phosphate-buffered saline (PBS) and stored at ‒80°C. On the day of experiment,
50 × 10<sup>6</sup> cells were lysed with 2 mL of lysis buffer (10 mM HEPES with
pH 7.9, 10 mM KCl, 5 mM MgCl<sub>2</sub>, 10% glycerol, 10 mM adenosine
triphosphate [ATP], 1% NP40, protease Complete and phosphatase PhosSTOP
inhibitors from Roche), incubated for 15 minutes at 4°C, and sonicated
(Bioruptor Plus; Diagenode). Non-soluble debris were removed by centrifugation
(4000<italic>g</italic> for 15 minutes at 4°C) and the protein concentration
in the supernatant was determined by detergent-compatible (DC) assay (Bio-Rad).
Aliquots were kept at ‒80°C until analysis. Immunopurification of the endogenous
20S core proteasome was performed as described in Fabre et al.<sup><xref rid="bibr21-1177932219868223" ref-type="bibr">21</xref></sup></p>
    </sec>
    <sec id="section5-1177932219868223">
      <title>Intact protein and top-down MS analysis</title>
      <p>Nano-LC-MS and MS/MS analyses of commercial or immunopurified 20S were performed
on a nanoRS UHPLC system (Dionex) coupled to an LTQ-Orbitrap Fusion Tribrid mass
spectrometer (Thermo Fisher Scientific). A total of 5 μL of sample at 0.3 µM was
loaded onto a reverse-phase C4-precolumn (300 μm i.d. × 5 mm; Thermo Fisher
Scientific) at 20 μL/min in 2% acetonitrile (ACN) and 0.2% formic acid (FA).
After 5 minutes of desalting, the precolumn was switched online with an
analytical C4 nanocolumn (75 μm i.d. × 15 cm; in-house packed with C4 Reprosil)
equilibrated in 95% solvent A (5% ACN, 0.2% FA) and 5% solvent B (0.2% FA in
ACN). Proteins were eluted using a binary gradient ranging from 5% to 40% (5
minutes) and then 40% to 99% (33 minutes) of solvent B at a flow rate of 300
nL/min. For the commercial 20S samples, the Fusion Tribrid (Thermo Fisher
Scientific) was operated in single MS acquisition mode with the Xcalibur
software (Thermo Fisher Scientific). The spray voltage was set to 1900 V, the
ion transfer tube temperature to 300°C, the RF lens to 60%, and the in-source
dissociation to 50 V. The MS scans were acquired in the 700 to 2000 m/z range
with the resolution set to 60 000 and using 10 µscans for averaging. For the
intact protein and top-down MS analysis of the immunopurified std20s, the spray
voltage was set to 1350 V, the ion transfer tube temperature to 270°C, the RF
lens to 60%, and the in-source dissociation to 50 V. The MS and MS/MS scans were
acquired in the 400 to 2000 m/z range with a resolution of 120 000 and using 3
µscans for averaging. Ions of interest were selected according to an inclusion
list of 14 precursor masses (corresponding to the 20S subunits) that were
analysed by MS/MS with the option “DDA if parent mass list not found” unchecked.
The isolation window was set to 5 Th with electron-transfer/higher-energy
collision dissociation (EThcD) fragmentation (electron-transfer dissociation
[ETD]: 20 ms and higher-energy collision dissociation [HCD]: 25%).</p>
    </sec>
    <sec id="section6-1177932219868223">
      <title>Data analysis and visualization</title>
      <p>For MS traces, raw files were automatically deconvoluted with the rolling window
deconvolution software RoWinPro<sup><xref rid="bibr8-1177932219868223" ref-type="bibr">8</xref></sup> and the proteoform footprints were visualized with VisioProt-MS v2.0.<sup><xref rid="bibr17-1177932219868223" ref-type="bibr">17</xref></sup> Top-down raw data were analyzed with Proteome Discoverer v2.2 (Thermo
Scientific) using the ProSight PD Top-Down Low/High node. Briefly, intact
protein spectra were deconvoluted with ReSpect (precursor mass between 20 000
and 30 000 Da and 100 ppm mass tolerance, charge state range between 15 and 35).
Tandem mass spectrometry spectra were deconvoluted with Xtract (S/N threshold =
3, m/z range between 200 and 2000 Da, 60 000 resolution) and searched against a
custom database including all human 20S subunits (generated in ProSight PC v4.0,
Thermo Scientific). The search was performed in absolute mass mode with a
fragment mass tolerance of 15 ppm and a precursor mass tolerance of 200 Da. The
MS/MS and proteoform-spectrum matches were visualized with VisioProt-MS. All the
figures were adapted from VisioProt-MS exports using Adobe Illustrator CS6
v16.0.0.</p>
    </sec>
  </sec>
  <sec id="section7-1177932219868223">
    <title>MS/MS Analysis of Immunopurified STD20s</title>
    <p>We analyzed the endogenous 20S immunopurified from human Hek293T-EBNA cells<sup><xref rid="bibr22-1177932219868223" ref-type="bibr">22</xref></sup> using intact protein and top-down MS. VisioProt-MS allowed the visualization
of the most intense proteoforms based on their deconvoluted MWs (<xref ref-type="fig" rid="fig1-1177932219868223">Figure 1A</xref>), and most of these
were confirmed by MS/MS (<xref ref-type="fig" rid="fig1-1177932219868223">Figure
1B</xref>). Besides the MS trace, the species selected for MS/MS during the
top-down analysis are indicated by empty or filled circles for non-matched MS/MS and
proteoform to spectrum matches, respectively. These can be dynamically explored with
the “Show data labels” option in the sidebar menu, which triggers dynamic labeling
of the data points on hovering. Then, passing the mouse over them informs on the
proteoform identified with each MS/MS and their RT, intensity, and deconvoluted MW.
It is also possible to highlight the MS/MS matched to specific proteoform(s) of
interest such as β6 (PSMB1; <xref ref-type="fig" rid="fig1-1177932219868223">Figure
1B</xref>, red points). The most intense proteoforms identified in this sample
are presented in <xref rid="table1-1177932219868223" ref-type="table">Table 1</xref>
(indicated with the superscript “a”).</p>
    <fig id="fig1-1177932219868223" orientation="portrait" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Top-down analysis of immunopurified std20S: (A) 3D proteoform footprint of
the LC-MS trace of 20S subunits generated with VisioProt-MS. The names of
the std20S subunits are indicated next to the corresponding signal. (B) The
same sample analyzed with MS/MS fragmentation for identification and
visualized with the MS/MS mode of VisioProt-MS. The MS trace is color-coded
with the «Red/yellow/blue» scale, and the MS/MS identified as β6 are
indicated in red. Gray empty and filled circles are MS/MS that were not
identified or proteoform-spectrum matches, respectively. The 2 rectangular
selections (in red dashed lines) highlight (a) a non-identified proteoform
(corresponding to the phosphorylated α7—based on its MW), and (b) potential
false identifications (filled circles that do not overlap with a clear
deconvoluted MS trace). Both figures were drawn with a VisioProt-MS
«Threshold» parameter of 80%. LC-MS indicates liquid chromatography coupled
to mass spectrometry; MS, mass spectrometry; MW, molecular weight.</p>
      </caption>
      <graphic xlink:href="10.1177_1177932219868223-fig1"/>
    </fig>
    <p>Beyond allowing an easy exploration of the identified proteoforms, this
representation allows the quick detection of false identifications. For example, in
the box “b” (<xref ref-type="fig" rid="fig1-1177932219868223">Figure 1B</xref>),
some MS/MS have been matched to proteoforms in an empty area of the LC-MS map and
are most probably background noise. In addition, the single red point overlaid to
the β7 subunit MS trace corresponds to an MS/MS that was wrongly matched to β6
(<xref ref-type="fig" rid="fig1-1177932219868223">Figure 1B</xref>). This could
be due to an incorrect estimation of the precursor MW during deconvolution
(potential wrong charge state assignment), or a wrong proteoform to spectral
matching, and should not be taken into account for further analysis.</p>
    <p>In addition to facilitating data curation, the MS/MS mode of VisioProt-MS can be used
to optimize the acquisition and search parameters. The dashed rectangle “a” in <xref ref-type="fig" rid="fig1-1177932219868223">Figure 1B</xref> highlights a
proteoform that was not identified by MS/MS. We can see in this figure that several
MS/MS were triggered on its elution, but none of them was matched to a protein
sequence. This can be due to miss-adapted acquisition methods or search parameters
that can be tuned to increase the number of proteoforms identified. In this sample,
α7 is mostly phosphorylated, as reported in Gersch et al.<sup><xref rid="bibr8-1177932219868223" ref-type="bibr">8</xref></sup></p>
  </sec>
  <sec id="section8-1177932219868223">
    <title>Comparison of the std20S and i20S</title>
    <p>To demonstrate the advantages of VisioProt-MS in the context of comparative sample
analysis, we chose the commercial samples of std20S and i20S. Their LC-MS maps are
presented in <xref ref-type="fig" rid="fig2-1177932219868223">Figure 2</xref>, first
alone with color-coded intensities (<xref ref-type="fig" rid="fig2-1177932219868223">Figure 2A</xref> and <xref ref-type="fig" rid="fig2-1177932219868223">B</xref>)
and together for their direct comparison (<xref ref-type="fig" rid="fig2-1177932219868223">Figure 2C</xref>). These graphical representations
indicate the unexpected presence of the subunits β1, β2, and β5 among the
i20S-specific subunits of the i20S sample, thereby highlighting a contamination by
the std20S (<xref ref-type="fig" rid="fig2-1177932219868223">Figure 2B</xref>).</p>
    <fig id="fig2-1177932219868223" orientation="portrait" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>Comparison of commercial std20S and i20S using intact protein MS: (A, B) MS
trace of the subunits of the std20S (A, threshold: 35%) and i20s (B,
threshold: 16%) visualized with VisioProt-MS in MS mode. The names of the
identified subunits are indicated next to the corresponding signal. The
subunits that are specific to the standard or immunoproteasome are indicated
in blue and red, respectively. (C) Overlay of the same samples for
comparison of their proteoform composition (threshold: 35%). The MS trace is
color-coded in function of the sample. A magnification of the area indicated
with the dashed rectangular selection (“beta5 and beta5i”) is presented on
the right. The names of the identified subunits are indicated next to the
corresponding signal. The 3 beta5 traces correspond to the mature protein
with 0, 1, or 2 oxidations. MS indicates mass spectrometry.</p>
      </caption>
      <graphic xlink:href="10.1177_1177932219868223-fig2"/>
    </fig>
    <p>Similar graphical representations can be used in other contexts beyond heterogeneous
complex analysis, such as identification of covalent drug binding,<sup><xref rid="bibr8-1177932219868223" ref-type="bibr">8</xref></sup> monitoring of protein maturation/processing, or identification of
context-dependent post-translational modifications or protein variants.<sup><xref rid="bibr23-1177932219868223" ref-type="bibr">23</xref><xref rid="bibr24-1177932219868223" ref-type="bibr"/>-<xref rid="bibr25-1177932219868223" ref-type="bibr">25</xref></sup> Besides zooming and dynamic
labeling of the data points, VisioProt-MS allows the user to hide
experiment-dependent background noise with the “Threshold” option of the sidebar
menu. This defines the percentage of high-intensity MS signal that is visualized on
the LC-MS map. It is also possible to mask/unmask sample traces by clicking on their
legends, which facilitates the exploration of overlapping signals such as the ones
of β5 in <xref ref-type="fig" rid="fig2-1177932219868223">Figure 2C</xref>.</p>
  </sec>
  <sec sec-type="conclusions" id="section9-1177932219868223">
    <title>Conclusions</title>
    <p>For many years, the composition of the 20S core particle of the human proteasome was
analyzed with methods such as low-resolution two-dimensional (2D) sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) separation coupled with
analytical techniques (Western blotting or protein/peptide extraction followed by MS
analysis).<sup><xref rid="bibr19-1177932219868223" ref-type="bibr">19</xref>,<xref rid="bibr26-1177932219868223" ref-type="bibr">26</xref></sup> These methods prove the efficiency of 2D representations for
mapping proteoforms of complex samples. However, such strategies are experimentally
heavy, require a high amount of starting material, and rely on a priori knowledge on
the different proteoforms present in the samples. Intact protein and top-down MS
remain limited in sensitivity and dynamic range. Furthermore, high-MW proteoforms
are still very challenging to study with these techniques. Nevertheless, their
ability to precisely measure proteoform MWs and fragment them in a system-wide setup
already allows their application to the hypothesis-free exploration of complex samples.<sup><xref rid="bibr27-1177932219868223" ref-type="bibr">27</xref></sup> We believe that this could open the doors to personalized medicine at the
proteoform level but would rely on technological progresses that go along with an
increasing need for dedicated tools to facilitate data analysis.</p>
    <p>VisioProt-MS is an easy solution to visualize and inspect intact protein and top-down
MS data. It quickly provides an overview of all the detected MWs, reflecting data
quality and reproducibility regarding observed MWs, intensities, and RTs. It allows
comparison of not only multiple LC-MS runs (including from different deconvolution
suites), but also LC-MS and LC-MS/MS runs of the same sample. Furthermore, its
dynamic features enable to pinpoint potential new proteoforms, quickly reject
wrongly assigned Proteoform Spectral Matches, and spot intense MS signals that
remain unassigned.</p>
    <p>Today, VisioProt-MS v2.0 is compatible with the following bioinformatics tools: RoWinPro,<sup><xref rid="bibr8-1177932219868223" ref-type="bibr">8</xref></sup> Intact Protein Analysis (BioPharma Finder 3.0, Thermo Fisher Scientific),
DataAnalysis 4.2 (Bruker),<sup><xref rid="bibr9-1177932219868223" ref-type="bibr">9</xref></sup> TopFD (TopPIC Suite),<sup><xref rid="bibr10-1177932219868223" ref-type="bibr">10</xref></sup> and ProMex (Informed-Proteomics)<sup><xref rid="bibr11-1177932219868223" ref-type="bibr">11</xref></sup> for deconvoluted LC-MS data; and ProSight PD (Proteome Discoverer, Thermo),
TopPIC (TopPIC Suite),<sup><xref rid="bibr10-1177932219868223" ref-type="bibr">10</xref></sup> and MSPathFinder (Informed-Proteomics)<sup><xref rid="bibr11-1177932219868223" ref-type="bibr">11</xref></sup> for the LC-MS/MS data. It is open source and has been developed to be easily
adaptable to other formats that may materialize from future technological
development. Alternatively, it can be adapted and included in more complex
workflows. All the information concerning its features, compatibility, and usages
can be found in Locard-Paulet et al<sup><xref rid="bibr17-1177932219868223" ref-type="bibr">17</xref></sup> and on the associated online help (<ext-link ext-link-type="uri" xlink:href="https://masstools.ipbs.fr/visioprothelp.html">https://masstools.ipbs.fr/visioprothelp.html</ext-link>).</p>
  </sec>
</body>
<back>
  <fn-group>
    <fn fn-type="financial-disclosure">
      <p><bold>Funding:</bold>The author(s) disclosed receipt of the following financial support for the
research, authorship, and/or publication of this article: This work was
supported by the Novo Nordisk Foundation (NNF14CC0001), the French Ministry of
Research (Investissements d’Avenir Program, Proteomics French Infrastructure,
ANR-10-INBS-08) and the Fonds Européens de Développement Régional Toulouse
Métropôle and the Région Midi-Pyrénées.</p>
    </fn>
    <fn fn-type="COI-statement">
      <p><bold>Declaration of conflicting interests:</bold>The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p>
    </fn>
    <fn fn-type="other">
      <p><bold>Authors’ note:</bold> Jean Lesne is now affiliated with Centre de Biochimie Structurale, CNRS UMR5048,
INSERM U1054, Université de Montpellier, Montpellier, France.</p>
    </fn>
    <fn fn-type="con">
      <p><bold>Author Contributions:</bold> MLP and JM conceived this commentary. JM and JL performed the experiments and MS
analysis. MLP wrote the manuscript in consultation with JM, JL and MPB.</p>
    </fn>
    <fn fn-type="other">
      <p><bold>Data Availability:</bold> Raw files corresponding to the analysis of the commercial std20S
(OFJMX180306_15.raw) and i20S (OFJMX180306_18.raw) as well as immunopurified
std20S in MS (OFJMX160905_42.raw) and MS/MS (OFJMX160905_30.raw) have been
deposited to the MassIVE repository with the dataset identifier MSV000084069
(ftp://massive.ucsd.edu/MSV000084069).</p>
    </fn>
    <fn fn-type="other">
      <p><bold>ORCID iDs:</bold> Julien Marcoux <inline-graphic xlink:href="10.1177_1177932219868223-img1.jpg"/>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-7321-7436">https://orcid.org/0000-0001-7321-7436</ext-link></p>
      <p>Marie Locard-Paulet <inline-graphic xlink:href="10.1177_1177932219868223-img1.jpg"/>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-2879-9224">https://orcid.org/0000-0003-2879-9224</ext-link></p>
    </fn>
  </fn-group>
  <ref-list>
    <title>References</title>
    <ref id="bibr1-1177932219868223">
      <label>1</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>JC</given-names></name><name><surname>Zamdborg</surname><given-names>L</given-names></name><name><surname>Ahlf</surname><given-names>DR</given-names></name></person-group><etal>et al</etal><article-title>Mapping intact protein
isoforms in discovery mode using top-down proteomics</article-title>.
<source>Nature</source>.
<year>2011</year>;<volume>480</volume>:<fpage>254</fpage>-<lpage>258</lpage>.<pub-id pub-id-type="pmid">22037311</pub-id></mixed-citation>
    </ref>
    <ref id="bibr2-1177932219868223">
      <label>2</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durbin</surname><given-names>KR</given-names></name><name><surname>Fornelli</surname><given-names>L</given-names></name><name><surname>Fellers</surname><given-names>RT</given-names></name><name><surname>Doubleday</surname><given-names>PF</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Kelleher</surname><given-names>NL.</given-names></name></person-group><article-title>Quantitation and identification of thousands of human proteoforms
below 30 kDa</article-title>. <source>J Proteome Res</source>.
<year>2016</year>;<volume>15</volume>:<fpage>976</fpage>-<lpage>982</lpage>.<pub-id pub-id-type="pmid">26795204</pub-id></mixed-citation>
    </ref>
    <ref id="bibr3-1177932219868223">
      <label>3</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ntai</surname><given-names>I</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Fellers</surname><given-names>RT</given-names></name></person-group><etal>et al</etal><article-title>Applying label-free
quantitation to top down proteomics</article-title>. <source>Anal
Chem</source>.
<year>2014</year>;<volume>86</volume>:<fpage>4961</fpage>-<lpage>4968</lpage>.<pub-id pub-id-type="pmid">24807621</pub-id></mixed-citation>
    </ref>
    <ref id="bibr4-1177932219868223">
      <label>4</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>LM</given-names></name><name><surname>Kelleher</surname><given-names>NL.</given-names></name></person-group><article-title>Proteoform: a single term describing protein
complexity</article-title>. <source>Nat Methods</source>.
<year>2013</year>;<volume>10</volume>:<fpage>186</fpage>-<lpage>187</lpage>.<pub-id pub-id-type="pmid">23443629</pub-id></mixed-citation>
    </ref>
    <ref id="bibr5-1177932219868223">
      <label>5</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>KA</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Ge</surname><given-names>Y.</given-names></name></person-group><article-title>Top-down proteomics: ready for prime time?</article-title><source>Anal Chem</source>.
<year>2018</year>;<volume>90</volume>:<fpage>110</fpage>-<lpage>127</lpage>.<pub-id pub-id-type="pmid">29161012</pub-id></mixed-citation>
    </ref>
    <ref id="bibr6-1177932219868223">
      <label>6</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeDuc</surname><given-names>RD</given-names></name><name><surname>Schwämmle</surname><given-names>V</given-names></name><name><surname>Shortreed</surname><given-names>MR</given-names></name></person-group><etal>et al</etal><article-title>ProForma: a standard
proteoform notation</article-title>. <source>J Proteome Res</source>.
<year>2018</year>;<volume>17</volume>:<fpage>1321</fpage>-<lpage>1325</lpage>.<pub-id pub-id-type="pmid">29397739</pub-id></mixed-citation>
    </ref>
    <ref id="bibr7-1177932219868223">
      <label>7</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lermyte</surname><given-names>F</given-names></name><name><surname>Tsybin</surname><given-names>YO</given-names></name><name><surname>O’Connor</surname><given-names>PB</given-names></name><name><surname>Loo</surname><given-names>JA.</given-names></name></person-group><article-title>Top or middle? Up or down? Toward a standard lexicon for protein
top-down and allied mass spectrometry approaches</article-title>. <source>J
Am Soc Mass Spectrom</source>.
<year>2019</year>;<volume>30</volume>:<fpage>1149</fpage>-<lpage>1157</lpage>.<pub-id pub-id-type="pmid">31073892</pub-id></mixed-citation>
    </ref>
    <ref id="bibr8-1177932219868223">
      <label>8</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gersch</surname><given-names>M</given-names></name><name><surname>Hackl</surname><given-names>MW</given-names></name><name><surname>Dubiella</surname><given-names>C</given-names></name><name><surname>Dobrinevski</surname><given-names>A</given-names></name><name><surname>Groll</surname><given-names>M</given-names></name><name><surname>Sieber</surname><given-names>SA.</given-names></name></person-group><article-title>A mass spectrometry platform for a streamlined investigation of
proteasome integrity, posttranslational modifications, and inhibitor
binding</article-title>. <source>Chem Biol</source>.
<year>2015</year>;<volume>22</volume>:
<fpage>404</fpage>-<lpage>411</lpage>.<pub-id pub-id-type="pmid">25728267</pub-id></mixed-citation>
    </ref>
    <ref id="bibr9-1177932219868223">
      <label>9</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmit</surname><given-names>P-O</given-names></name><name><surname>Vialaret</surname><given-names>J</given-names></name><name><surname>Wessels van Gool</surname><given-names>AJ</given-names></name></person-group><etal>et al</etal><article-title>Towards a routine application
of top-down approaches for label-free discovery workflows</article-title>.
<source>J Proteomics</source>.
<year>2018</year>;<volume>175</volume>:<fpage>12</fpage>-<lpage>26</lpage>.<pub-id pub-id-type="pmid">28855124</pub-id></mixed-citation>
    </ref>
    <ref id="bibr10-1177932219868223">
      <label>10</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kou</surname><given-names>Q</given-names></name><name><surname>Xun</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name></person-group><article-title>TopPIC: a software tool for top-down mass spectrometry-based
proteoform identification and characterization</article-title>.
<source>Bioinformatics</source>.
<year>2016</year>;<volume>32</volume>:<fpage>3495</fpage>-<lpage>3497</lpage>.<pub-id pub-id-type="pmid">27423895</pub-id></mixed-citation>
    </ref>
    <ref id="bibr11-1177932219868223">
      <label>11</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Piehowski</surname><given-names>PD</given-names></name><name><surname>Wilkins</surname><given-names>C</given-names></name></person-group><etal>et al</etal><article-title>Informed-proteomics:
open-source software package for top-down proteomics</article-title>.
<source>Nat Methods</source>.
<year>2017</year>;<volume>14</volume>:<fpage>909</fpage>-<lpage>914</lpage>.<pub-id pub-id-type="pmid">28783154</pub-id></mixed-citation>
    </ref>
    <ref id="bibr12-1177932219868223">
      <label>12</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durbin</surname><given-names>KR</given-names></name><name><surname>Tran</surname><given-names>JC</given-names></name><name><surname>Zamdborg</surname><given-names>L</given-names></name></person-group><etal>et al</etal><article-title>Intact mass detection,
interpretation, and visualization to automate top-down proteomics on a large
scale</article-title>. <source>Proteomics</source>.
<year>2010</year>;<volume>10</volume>:<fpage>3589</fpage>-<lpage>3597</lpage>.<pub-id pub-id-type="pmid">20848673</pub-id></mixed-citation>
    </ref>
    <ref id="bibr13-1177932219868223">
      <label>13</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plymire</surname><given-names>DA</given-names></name><name><surname>Wing</surname><given-names>CE</given-names></name><name><surname>Robinson</surname><given-names>DE</given-names></name><name><surname>Patrie</surname><given-names>SM.</given-names></name></person-group><article-title>Continuous elution proteoform identification of myelin basic
protein by superficially porous reversed-phase liquid chromatography and
Fourier transform mass spectrometry</article-title>. <source>Anal
Chem</source>.
<year>2017</year>;<volume>89</volume>:<fpage>12030</fpage>-<lpage>12038</lpage>.<pub-id pub-id-type="pmid">29016107</pub-id></mixed-citation>
    </ref>
    <ref id="bibr14-1177932219868223">
      <label>14</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S-W</given-names></name><name><surname>Berger</surname><given-names>SJ</given-names></name><name><surname>Martinović</surname><given-names>S</given-names></name></person-group><etal>et al</etal><article-title>Direct mass spectrometric
analysis of intact proteins of the yeast large ribosomal subunit using
capillary LC/FTICR</article-title>. <source>Proc Natl Acad Sci U S
A</source>.
<year>2002</year>;<volume>99</volume>:<fpage>5942</fpage>-<lpage>5947</lpage>.<pub-id pub-id-type="pmid">11983894</pub-id></mixed-citation>
    </ref>
    <ref id="bibr15-1177932219868223">
      <label>15</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carel</surname><given-names>C</given-names></name><name><surname>Marcoux</surname><given-names>J</given-names></name><name><surname>Réat</surname><given-names>V</given-names></name></person-group><etal>et al</etal><article-title>Identification of specific
posttranslational O-mycoloylations mediating protein targeting to the
mycomembrane</article-title>. <source>Proc Natl Acad Sci U S A</source>.
<year>2017</year>;<volume>114</volume>:<fpage>4231</fpage>-<lpage>4236</lpage>.<pub-id pub-id-type="pmid">28373551</pub-id></mixed-citation>
    </ref>
    <ref id="bibr16-1177932219868223">
      <label>16</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parra</surname><given-names>J</given-names></name><name><surname>Marcoux</surname><given-names>J</given-names></name><name><surname>Poncin</surname><given-names>I</given-names></name></person-group><etal>et al</etal><article-title>Scrutiny of
<italic>Mycobacterium tuberculosis</italic> 19 kDa antigen proteoforms
provides new insights in the lipoglycoprotein biogenesis
paradigm</article-title>. <source>Sci Rep</source>.
<year>2017</year>;<volume>7</volume>:<fpage>43682</fpage>.<pub-id pub-id-type="pmid">28272507</pub-id></mixed-citation>
    </ref>
    <ref id="bibr17-1177932219868223">
      <label>17</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locard-Paulet</surname><given-names>M</given-names></name><name><surname>Parra</surname><given-names>J</given-names></name><name><surname>Albigot</surname><given-names>R</given-names></name></person-group><etal>et al</etal><article-title>VisioProt-MS: interactive 2D
maps from intact protein mass spectrometry</article-title>.
<source>Bioinformatics</source>.
<year>2018</year>;<volume>35</volume>:<fpage>679</fpage>-<lpage>681</lpage>.</mixed-citation>
    </ref>
    <ref id="bibr18-1177932219868223">
      <label>18</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thibaudeau</surname><given-names>TA</given-names></name><name><surname>Smith</surname><given-names>DM.</given-names></name></person-group><article-title>A practical review of proteasome pharmacology</article-title>.
<source>Pharmacol Rev</source>.
<year>2019</year>;<volume>71</volume>:<fpage>170</fpage>-<lpage>197</lpage>.<pub-id pub-id-type="pmid">30867233</pub-id></mixed-citation>
    </ref>
    <ref id="bibr19-1177932219868223">
      <label>19</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bousquet-Dubouch</surname><given-names>M-P</given-names></name><name><surname>Fabre</surname><given-names>B</given-names></name><name><surname>Monsarrat</surname><given-names>B</given-names></name><name><surname>Burlet-Schiltz</surname><given-names>O.</given-names></name></person-group><article-title>Proteomics to study the diversity and dynamics of proteasome
complexes: from fundamentals to the clinic</article-title>. <source>Expert
Rev Proteomics</source>.
<year>2011</year>;<volume>8</volume>:<fpage>459</fpage>-<lpage>481</lpage>.<pub-id pub-id-type="pmid">21819302</pub-id></mixed-citation>
    </ref>
    <ref id="bibr20-1177932219868223">
      <label>20</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bousquet-Dubouch</surname><given-names>M-P</given-names></name><name><surname>Baudelet</surname><given-names>E</given-names></name><name><surname>Guérin</surname><given-names>F</given-names></name></person-group><etal>et al</etal><article-title>Affinity purification strategy
to capture human endogenous proteasome complexes diversity and to identify
proteasome-interacting proteins</article-title>. <source>Mol Cell
Proteomics</source>. <year>2009</year>;<volume>8</volume>:
<fpage>1150</fpage>-<lpage>1164</lpage>.<pub-id pub-id-type="pmid">19193609</pub-id></mixed-citation>
    </ref>
    <ref id="bibr21-1177932219868223">
      <label>21</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabre</surname><given-names>B</given-names></name><name><surname>Lambour</surname><given-names>T</given-names></name><name><surname>Garrigues</surname><given-names>L</given-names></name></person-group><etal>et al</etal><article-title>Label-free quantitative
proteomics reveals the dynamics of proteasome complexes composition and
stoichiometry in a wide range of human cell lines</article-title>. <source>J
Proteome Res</source>.
<year>2014</year>;<volume>13</volume>:<fpage>3027</fpage>-<lpage>3037</lpage>.<pub-id pub-id-type="pmid">24804812</pub-id></mixed-citation>
    </ref>
    <ref id="bibr22-1177932219868223">
      <label>22</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillaume</surname><given-names>B</given-names></name><name><surname>Chapiro</surname><given-names>J</given-names></name><name><surname>Stroobant</surname><given-names>V</given-names></name></person-group><etal>et al</etal><article-title>Two abundant proteasome
subtypes that uniquely process some antigens presented by HLA class I
molecules</article-title>. <source>Proc Natl Acad Sci U S A</source>.
<year>2010</year>;<volume>107</volume>:<fpage>18599</fpage>-<lpage>18604</lpage>.<pub-id pub-id-type="pmid">20937868</pub-id></mixed-citation>
    </ref>
    <ref id="bibr23-1177932219868223">
      <label>23</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ntai</surname><given-names>I</given-names></name><name><surname>Fornelli</surname><given-names>L</given-names></name><name><surname>DeHart</surname><given-names>CJ</given-names></name></person-group><etal>et al</etal><article-title>Precise characterization of
KRAS4b proteoforms in human colorectal cells and tumors reveals
mutation/modification cross-talk</article-title>. <source>Proc Natl Acad Sci
U S A</source>.
<year>2018</year>;<volume>115</volume>:<fpage>4140</fpage>-<lpage>4145</lpage>.<pub-id pub-id-type="pmid">29610327</pub-id></mixed-citation>
    </ref>
    <ref id="bibr24-1177932219868223">
      <label>24</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Paša-Tolić</surname><given-names>L</given-names></name><name><surname>Stenoien</surname><given-names>DL.</given-names></name></person-group><article-title>Profiling of histone post-translational modifications in mouse
brain with high-resolution top-down mass spectrometry</article-title>.
<source>J Proteome Res</source>.
<year>2017</year>;<volume>16</volume>:<fpage>599</fpage>-<lpage>608</lpage>.<pub-id pub-id-type="pmid">28001079</pub-id></mixed-citation>
    </ref>
    <ref id="bibr25-1177932219868223">
      <label>25</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Waterbeemd</surname><given-names>M</given-names></name><name><surname>Tamara</surname><given-names>S</given-names></name><name><surname>Fort</surname><given-names>KL</given-names></name></person-group><etal>et al</etal><article-title>Dissecting ribosomal particles
throughout the kingdoms of life using advanced hybrid mass spectrometry
methods</article-title>. <source>Nat Commun</source>.
<year>2018</year>;<volume>9</volume>:<year>2493</year>.</mixed-citation>
    </ref>
    <ref id="bibr26-1177932219868223">
      <label>26</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drews</surname><given-names>O</given-names></name><name><surname>Wildgruber</surname><given-names>R</given-names></name><name><surname>Zong</surname><given-names>C</given-names></name></person-group><etal>et al</etal><article-title>Mammalian proteasome
subpopulations with distinct molecular compositions and proteolytic
activities</article-title>. <source>Mol Cell Proteomics</source>.
<year>2007</year>;<volume>6</volume>:<fpage>2021</fpage>-<lpage>2031</lpage>.<pub-id pub-id-type="pmid">17660509</pub-id></mixed-citation>
    </ref>
    <ref id="bibr27-1177932219868223">
      <label>27</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savaryn</surname><given-names>JP</given-names></name><name><surname>Toby</surname><given-names>TK</given-names></name><name><surname>Catherman</surname><given-names>AD</given-names></name></person-group><etal>et al</etal><article-title>Comparative top down
proteomics of peripheral blood mononuclear cells from kidney transplant
recipients with normal kidney biopsies or acute rejection</article-title>.
<source>Proteomics</source>.
<year>2016</year>;<volume>16</volume>:<fpage>2048</fpage>-<lpage>2058</lpage>.<pub-id pub-id-type="pmid">27120713</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
